Drug profile · INN
mupirocin calcium
MUPIROCIN
mupirocin calcium (MUPIROCIN) is a isoleucyl-trna synthetase inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: topical. Current US regulatory status: approved.
Drug details — mupirocin calcium
- US status
- approved
- Class
- —
- Route
- TOPICAL
- Patents
- 1
- Programs
- 3
- Data quality
- 0.89
Quick answer
mupirocin calcium (MUPIROCIN) is a isoleucyl-trna synthetase inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: topical. Current US regulatory status: approved.
Key facts
Mechanism of action
Isoleucyl-tRNA synthetase inhibitor
Primary target: Isoleucine--tRNA ligase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
Frequently asked questions
What is mupirocin calcium?
mupirocin calcium (MUPIROCIN) is a isoleucyl-trna synthetase inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: topical. Current US regulatory status: approved.
What is the brand name for mupirocin calcium?
MUPIROCIN is a marketed brand name for mupirocin calcium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of mupirocin calcium?
mupirocin calcium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.